Oralair Market Report 2026

Oralair Market Overview

• The Oralair market growth in the historic period has been driven by rising prevalence of seasonal allergic rhinitis, increased awareness of allergy immunotherapy benefits • Market expansion is supported by growing demand for disease-modifying allergy therapies, increasing adoption of personalized allergy treatments • Growth Driver: Rising Prevalence Of Allergic Conditions Driving Growth In The Market • Europe was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oralair Market?

Oralair is an allergy immunotherapy treatment for grass pollen-induced allergic rhinitis, with or without conjunctivitis. It works by desensitizing the immune system to grass pollen allergens, reducing the severity of allergic reactions over time. It is designed as a long-term solution and helps alleviate symptoms by gradually exposing the body to allergens, effectively managing grass pollen allergies. The main types of indications for oralair are allergic rhinitis, conjunctivitis, and allergic asthma. Allergic rhinitis is the irritation of the nasal passages caused by allergens, leading to symptoms such as sneezing, congestion, and a runny nose. It is distributed through several distribution channels, such as pharmacies, hospitals, clinics, and specialty clinics, and is used by various end users, including adults, adolescents, and children.

What Is The Oralair Market Growth Forecast?

The growth in the forecast period can be attributed to growing demand for disease-modifying allergy therapies, increasing adoption of personalized allergy treatments, expansion of immunotherapy use in pediatric populations, rising investments in allergy biologics research, broader reimbursement support for immunotherapy. Major trends in the forecast period include increasing adoption of sublingual immunotherapy, rising preference for long-term allergy desensitization treatments, growing use of standardized allergen extracts, expansion of preventive allergy management approaches, enhanced focus on patient adherence programs.

Global Oralair Market Segmentation

1) By Indication: Allergic Rhinitis, Conjunctivitis, Allergic Asthma 2) By Distribution Channel: Pharmacies, Hospitals And Clinics, Specialty Clinics 3) By End-User: Adults, Adolescents, Children

What Are The Drivers Of The Oralair Market?

The rising prevalence of allergic conditions is expected to propel the growth of the oralair market going forward. Allergic conditions are immune system responses to allergens, which are substances that trigger symptoms such as itching, swelling, and inflammation. The prevalence of allergic conditions is driven by increased air pollution, environmental changes, and genetic predispositions. Oralair gradually desensitizes the immune system to allergens like grass pollen, reducing sensitivity over time. This helps alleviate symptoms and provides long-term relief from allergic reactions. For instance, in June 2023, according to the Department of Health, Victoria, an Australia-based state government agency, allergic diseases impact close to 20% of Australia’s population, and forecasts suggest that by 2050 the patient population could surge by 70%, reaching approximately 7.7 million people. Therefore, the rising prevalence of allergic conditions is driving the growth of the oralair industry. The growing awareness of immunotherapy is set to propel the growth of the oralair market moving forward. Immunotherapy is a treatment that leverages the body's immune system to combat diseases by boosting or altering immune responses. The demand for immunotherapy is rising due to advancements in immune-based therapies, growing awareness of immunotherapy's effectiveness, and a shift toward personalized medicine. Oralair acts as an allergy immunotherapy that desensitizes the immune system to grass pollen and offers a targeted, lasting treatment for allergic rhinitis. For instance, in June 2025, the Cancer Research Institute, a US-based nonprofit organization focused on advancing cancer immunotherapy research and clinical translation, reported that in 2024 alone, the US Food and Drug Administration granted 17 new immunotherapy approvals compared to prior years. Therefore, growing awareness of immunotherapy is driving the growth of the oralair industry. The increase in healthcare spending is significantly driving the growth of the oralair market in the future. Healthcare spending is allocating financial resources for medical services, treatments, and other related healthcare costs over a specific period. Healthcare spending is rising due to factors such as an aging population, increasing prevalence of chronic diseases, advancements in medical technologies, and the growing demand for better healthcare services. Rising healthcare costs are prompting patients and providers to prioritize long-term solutions, making Oralair a preferred, cost-effective option for managing allergic rhinitis. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based institute for health information, in 2023, total health spending in Canada is projected to reach $344 billion, equating to $8,740 per person. It is a 2.8% increase compared to the previous year, which saw only a 1.5% growth in health spending in 2022, indicating a notable rebound in healthcare investment. Therefore, an increase in healthcare spending is driving the growth of the oralair industry.

Key Players In The Global Oralair Market

Major companies operating in the oralair market are Stallergenes Greer

Regional Insights

Europe was the largest region in the oralair market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Oralair Market?

The oralair market consists of sales of allergen extracts and sublingual tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oralair Market Report 2026?

The oralair market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oralair industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.